Brief: Entrada Therapeutics Says Expanded Size Of Board From Seven To Eight Directors
04/04/2023 13:04
April 4 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* ENTRADA THERAPEUTICS INC - EXPANDED SIZE OF BOARD FROM
SEVEN TO
EIGHT DIRECTORS
Further company coverage: TRDA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview